The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 272-277

  Li, Jun Xu ^a   Thorn, David A ^a   Jin, Chunyang ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Discriminative stimulus; GPR88; Locomotor activity; Methamphetamine; Rat

Indexed keywords

2 PYRIDIN 2 YLCYCLOPROPANE CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GRP88 RECEPTOR; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; HYPERACTIVITY; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; CHROMANS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; METHAMPHETAMINE; P-CHLOROAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84871921546     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.037     Document Type: Article

References (22)

1. Bates, B., Logue, S.F., Pausch, M., 2008. Methods of identifying agents for treating neurological disorders, US Patent 0039535 A1, USA.
2. Bi, Y., Dzierba, C.D., Bronson, J.J., Fink, C., Green, M., Kimball, D., Macor, J.E., Kwon, S., Zhang, Y., Zipp, G., 2011. Modulators of G protein-Coupled Receptor 88. US Patent 0251204 A1, USA.
3. P. Bo, E. Marchioni, C. Dallocchio, A. Albergati, and F. Savoldi Antagonism of EEGraphic and behavioural effects of methamphetamine by selective receptor blockers (SCH 23390 and raclopride) in the rabbit Prog. Neuropsychopharmacol. Biol. Psychiatry 15 1991 803 815
4. P.W. Czoty, C.R. Ramanathan, N.H. Mutschler, A. Makriyannis, and J. Bergman Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors J. Pharmacol. Exp. Ther. 311 2004 720 727 (Pubitemid 39391560)
5. R.I. Desai, C.A. Paronis, J. Martin, R. Desai, and J. Bergman Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux J. Pharmacol. Exp. Ther. 333 2010 834 843
6. A.E. Fleckenstein, T.J. Volz, and G.R. Hanson Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications Neuropharmacology 56 1 2009 133 138
7. R. Hassler Striatal control of locomotion, intentional actions and of integrating and perceptive activity J. Neurol. Sci. 36 1978 187 224 (Pubitemid 8301731)
8. J.X. Li, K.C. Rice, and C.P. France Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity Behav. Pharmacol. 18 2007 283 288 (Pubitemid 46884164)
9. J.X. Li, and Y. Zhang Emerging drug targets for pain treatment Eur. J. Pharmacol. 681 2012 1 5
10. S.F. Logue, S.M. Grauer, J. Paulsen, R. Graf, N. Taylor, M.A. Sung, L. Zhang, Z. Hughes, V.L. Pulito, F. Liu, S. Rosenzweig-Lipson, N.J. Brandon, K.L. Marquis, B. Bates, and M. Pausch The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders? Mol. Cell. Neurosci. 42 2009 438 447
11. R. Massart, J.P. Guilloux, V. Mignon, P. Sokoloff, and J. Diaz Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents Eur. J. Neurosci. 30 2009 397 414
12. P. Munzar, and S.R. Goldberg Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats Psychopharmacology (Berl.) 148 2000 209 216 (Pubitemid 30104144)
13. A. Nakajima, K. Yamada, J. He, N. Zeng, A. Nitta, and T. Nabeshima Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats J. Neurochem. 91 2004 308 317 (Pubitemid 39363430)
14. Nicosia, N., Pacula, R., Kilmer, B., Lundberg, R., Chiesa, J., 2009. The Economic Cost of Methamphetamine Use in the United States, 2005. Drug Policy Res. Cent., RAND Corp., Santa Monica, CA.
15. NSDUH, 2007. Results from the 2007. National Survey on Drug Use and Health: National Findings. 〈http://oas.samhsa.gov/nsduh/2k7nsduh/ 2k7results.pdf〉.
16. M.R. Picciotto, and K. Wickman Using knockout and transgenic mice to study neurophysiology and behavior Physiol. Rev. 78 1998 1131 1163 (Pubitemid 28491951)
17. C. Sampson, Y. Zhang, F. Del Bello, and J.X. Li Effects of imidazoline I2 receptor ligands on acute nociception in rats Neuroreport 23 2012 73 77
18. R.J. Sevak, A.R. Vansickel, W.W. Stoops, P.E. Glaser, L.R. Hays, and C.R. Rush Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole J. Clin. Psychopharmacol. 31 2011 470 480
19. D.A. Thorn, X.F. An, Y. Zhang, M. Pigini, and J.X. Li Characterization of the hypothermic effects of imidazoline I(2) receptor agonists in rats Br. J. Pharmacol. 166 2011 1936 1945
20. UNODC, 2010. United Nations Office on Drugs and Crime. World Drug Report, 2010. Austria Vienna
21. Y. Watanabe, Y. Hori, M. Ohnishi, K. Sakurai, M. Yato, and T. Shibuya Inhibitory effects of newly synthesized Ser-contained GABA-peptides administered into either caudate putamen or amygdala on methamphetamine-induced hyperactivity Nihon Shinkei Seishin Yakurigaku Zasshi 15 1995 239 246
22. Y. Yan, A. Nitta, T. Mizuno, A. Nakajima, K. Yamada, and T. Nabeshima Discriminative- stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds Behav. Brain Res. 173 2006 39 46 (Pubitemid 44572014)